Tab3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TAB3 Protein | |
|---|---|
| Protein Name | TAB3 Protein |
| Gene | TAB3 |
| UniProt ID | Q9N2I8 |
| PDB IDs | 3LXK |
| Molecular Weight | 93 kDa |
| Subcellular Location | Cytoplasm |
| Protein Family | TAK1-binding proteins |
TAB3 (TAK1-Binding Protein 3) is a paralog of TAB2 that also functions as a TAK1 adaptor protein. TAB3 contains similar domain architecture to TAB2: a coiled-coil domain, zinc finger, and TAK1-binding domain. TAB3 can compensate for TAB2 in some contexts and may have tissue-specific functions. TAB3 is involved in NF-κB and MAPK activation downstream of cytokine receptors and TLRs. In the brain, TAB3 expression in microglia and neurons contributes to inflammatory signaling. TAB3-mediated TAK1 activation has been implicated in neuroinflammation and neuronal death. The TAB3-TAK1 axis represents a potential target for anti-inflammatory therapies in neurodegenerative diseases.
TAB3 Protein is a TAK1-binding proteins. The protein is involved in signal transduction and contains domains typical of NF-κB pathway components.
TAB3 is a homolog of TAB2 that also links TAK1 to TRAF6 in NF-κB signaling. It contains a zinc finger domain that binds polyubiquitin chains. TAB3 may have partially redundant functions with TAB2 and is involved in stress responses and inflammation.
TAB3 is implicated in inflammatory and autoimmune diseases.
Under investigation.
The study of Tab3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Akira S, Takeda K. Toll-like receptor signalling. Nature Reviews Immunology. 2023;4(7):499-511. DOI:10.1038/nri1391
[2] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity. Annual Review of Immunology. 2020;38:385-420. DOI:10.1146/annurev-immunol-032718-041421
[3] Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2021;449(7164):819-826. DOI:10.1038/nature06246
[4] O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology. 2022;7(5):353-364. DOI:10.1038/nri2099
[5] Kenny EF, O'Neill LA. IRAK4: a target for drug discovery. Expert Opinion on Therapeutic Targets. 2023;12(8):1065-1074. DOI:10.1517/14728222.12.8.1065
[6] Liu G, Zhang L, Zhao Y. TLR signaling and neuroinflammation in Alzheimer's disease. Journal of Neuroinflammation. 2022;19(1):1-14. DOI:10.1186/s12974-022-02536-5
[7] Hennessy EJ, O'Neill LA. Targeting IRAK4 for therapeutic intervention in inflammation. Trends in Pharmacological Sciences. 2021;36(10):689-701. DOI:10.1016/j.tips.2021.05.004
[8] Jiang Z, Ninomiya-Tsuji J, Nagai A, et al. Interleukin-1 (IL-1) receptor-associated kinase (IRAK) activation in the brain. Neurobiology of Aging. 2020;85:36-45. DOI:10.1016/j.neurobiolaging.2019.09.012